Two Sigma Advisers’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,507
Closed -$147K 2529
2020
Q3
$147K Buy
2,507
+1,580
+170% +$117K ﹤0.01% 2219
2020
Q2
$103K Sell
927
-33
-3% -$2.35K ﹤0.01% 2353
2020
Q1
$65K Buy
+960
New +$96.7K ﹤0.01% 2355
2019
Q3
Sell
-887
Closed -$94K 2351
2019
Q2
$94K Sell
887
-580
-40% -$76.4K ﹤0.01% 2218
2019
Q1
$227K Buy
1,467
+14
+1% +$1.62K ﹤0.01% 2081
2018
Q4
$135K Buy
+1,453
New +$208K ﹤0.01% 2194

Other funds holding OPTN

Two Sigma Advisers's OPTN Position: Q4 2020 in Review

Two Sigma Advisers sold out of OptiNose (OPTN) in Q4 2020, closing a stake of 2,507 shares — an estimated $147K sold.

Two Sigma Advisers first reported a position in OPTN in Q4 2018 and held it in 6 quarters. The position peaked at $227K in Q1 2019. 67 funds tracked by Wall St. Rank hold OPTN as of Q4 2020.

  • Two Sigma Advisers reported no remaining OptiNose position as of Q4 2020 after selling out during the quarter.
  • Two Sigma Advisers sold 2,507 OptiNose shares in Q4 2020, an estimated $147K.
  • Two Sigma Advisers first reported a position in OptiNose in Q4 2018 and held it in 6 quarters.
  • Two Sigma Advisers's OptiNose position peaked at $227K in Q1 2019.
  • 67 funds tracked by Wall St. Rank held OptiNose as of Q4 2020.

Based on Two Sigma Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.